Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Throat Lozenges Market Evolve in Terms of Growth and Size by 2029?

The market size of liraglutide has seen robust growth in the past few years. The market is expected to expand from $6.38 billion in 2024 to a value of $6.88 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.9%. Factors such as a rising prevalence of type 2 diabetes, increasing obesity rates, extensive clinical research, heightened awareness of the complications associated with diabetes, and advancements in drug delivery systems have all contributed to the growth experienced during the historic period.

In the coming years, the liraglutide market size is projected to witness remarkable growth. The market is anticipated to surge to “$9.45 billion in 2029 with a compound annual growth rate (CAGR) of 8.3%. Various reasons contributing to this growth in the anticipated period include the enhancement of insurance and reimbursement policies, development of medical infrastructure, raised awareness and educational measures, an increase in the aging population, and a high incidence rate of diabetes. Key trends for the forecast period encompass the integration of artificial intelligence and machine learning, an increasing affinity for wearable technology, incorporation of continuous glucose monitoring, advancements in biotechnology and the emergence of digital health platforms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

What factors are expected to fuel Throat Lozenges market growth in the coming years?

The throat lozenges market is projected to grow due to the escalating occurrence of respiratory ailments. These diseases typically affect the lungs and other components of the respiratory system. Throat lozenges play a key role in alleviating and treating infections and diseases within the respiratory tract. As an example, the Forum of International Respiratory Societies (FIRS), a US-based advocate for respiratory health, reported in September 2022 that around 200 million people worldwide suffer from chronic obstructive pulmonary disease, or COPD. This disease contributes to roughly 3.2 million deaths every year. Therefore, this rise in respiratory ailments is set to fuel the growth of the throat lozenges market.

The liraglutide market covered in this report is segmented –

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

Which Trends Are Redefining The Future Landscape Of The Throat Lozenges Industry?

In the liraglutide market, leading firms are diversifying their product offerings through the innovation of products such as generic GLP-1, catering to the growing need for cost-effective alternatives. Generic GLP-1 denotes GLP-1 receptor agonists produced once the original brand medications’ patent protection has expired, providing an economical option for managing conditions like obesity and type 2 diabetes. For example, Teva Pharmaceutical Industries Ltd, a pharmaceutical corporation based in Israel, launched the inaugural generic GLP-1, a product mirroring Victoza, into the U.S. market in June 2024. This move responded to the escalating demand for such treatments. Liraglutide injections are recommended for improving blood glucose control in children aged 10 and above as well as adults diagnosed with type 2 diabetes and in reducing cardiovascular event risks in adults suffering from type 2 diabetes along with pre-existing cardiovascular diseases.

What Are The Most Active Companies In The Throat Lozenges Market Today?

Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Which Regional Markets Are Attracting The Most Investment In Throat Lozenges?

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model